You think?
Based on their last Qtrly, another two years from Aug 23 until they need further funding. With recent increase in sales, looks promissing that they won't need it.
DYOR
- Forums
- ASX - By Stock
- CVB
- Ann: Sales Update for Q4 FY2024
Ann: Sales Update for Q4 FY2024, page-15
Featured News
Add CVB (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.010(10.0%) |
Mkt cap ! $34.93M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 11.0¢ | $45.73K | 415.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 113584 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 113584 | 0.100 |
2 | 18594 | 0.098 |
5 | 431505 | 0.095 |
1 | 24829 | 0.092 |
4 | 168494 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 20000 | 1 |
0.125 | 18181 | 1 |
0.135 | 7400 | 1 |
0.140 | 120000 | 2 |
0.155 | 54493 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
CVB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online